Selected Publications
Chong EA, Penuel E, Napier EB, Lundberg RK, Budde LE, Shadman M, Matasar MJ, Bartlett NL, Flinn IW, Bosch F, Fay K, Goy A, Kumar A, Nastoupil LJ, Wei MC, Wu M, Yin S, Fraietta JA, Chong ER, Schuster SJ: Impact of prior CAR-T cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas Blood Advances : 2024, accepted for publication.
Minehart J, Chong EA: Immune checkpoint inhibition and CAR T-cells: no longer exhausted? Transplantation and Cellular Therapy : 2024, accepted for publication.
Baron JA, Wright CM, Dreyfuss AD, Chong EA, Svoboda J, LaRiviere MJ, Jones JA, Maity A, Plastaras JP, Paydar I, Maxwell R.: Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell Lymphoma Pract Radiat Oncol 14 (5): e362-e372,2024.
Schneider M, Nasta SD, Barta SK, Chong EA, Svoboda J, Schuster SJ, Landsburg DJ.: Analysis of Histologic, Immunohistochemical and Genomic Features of Large B Cell Lymphoma Tumors May Predict Response to Polatuzumab Vedotin Based Therapy in Patients With Relapsed/Refractory Disease Clinical Lymphoma Myeloma & Leukemia online ahead of print : 2024.
Chong EA*, Kumashie KG, Chong ER, Fabrizio J, Gupta A, Svoboda J, Barta SK, Walsh KM, Napier EB, Lundberg RK, Nasta SD, Gerson JN, Landsburg DJ, Gonzalez J, Gaano A, Weirick ME, McAllister CM, Awofolaju M, John GN, Kammerman SC, Novacek J, Pajarillo R, Lundgreen KA, Tanenbaum N, Gouma S, Drapeau EM, Adamski S, D'Andrea K, Pattekar A, Hicks A, Korte S, Sharma H, Herring S, Williams JC, Hamilton JT, Bates P, Hensley SE, Prak ETL, Greenplate AR, Wherry EJ, Schuster SJ, Ruella M, Vella LA*: Immunologic predictors of vaccine responsiveness in patients with lymphoma and CLL The Journal of Infectious Diseases 230 (1): 15-27,2024.
Chong EA, Chong ER, Therwhanger D, Nasta SD, Landsburg DJ, Barta SK, Svoboda J, Gerson JN, Ghilardi G, Paruzzo L, Fraietta JA, Weber E, Stefano N, Porter DL, Frey NV, Garfall AL, Ruella M, Schuster SJ.: Bendamustine as lymphodepletion for brexucabtagene autoleucel therapy of mantle cell lymphoma Transplantation and Cellular Therapy 30 (7): 726.e1-726.e8,2024.
Bhansali RS, Ellin F, Relander T, Cao M, Li W, Long Q, Ganesan N, Stuver R, Horwitz SM, Wudhikarn K, Hwang SR, Bennani NN, Chavez J, Sokol L, Saeed H, Duan F, Porcu P, Pullarkat P, Mehta-Shah N, Zain JM, Ruiz M, Brammer JE, Prakash R, Iyer SP, Olszewski AJ, Major A, Riedell PA, Smith SM, Goldin C, Haverkos B, Hu B, Zhuang TZ, Allen PB, Toama W, Janakiram M, Brooks TR, Jagadeesh D, Hariharan N, Goodman AM, Hartman G, Ghione P, Fayyaz F, Rhodes JM, Chong EA, Gerson JN, Landsburg DJ, Nasta SD, Schuster SJ, Svoboda J, Jerkeman M, Barta SK: The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas Blood Advances 8 (13): 3507-3518,2024.
Akingbemi W, Kurtz G, Yegya-Raman N, Plastaras JP, Schuster SJ, Chong EA.: Stereotactic radiotherapy and CART for treatment of secondary CNS lymphoma Leukemia & Lymphoma 65 (6): 860-863,2024.
Chong, EA: CAR-T for large B-cell lymphomas: the clock is ticking Blood Advances 8 (11): 2980-2981,2024.
Chong, Elise A., Yuda, Junichiro, Izutsu, Koji, Fletcher, Luke Benjamin, Assaily, Wissam, Sahtout, Mohammad, Badawi, Mohamed, Burke, John M., Dean, James P., Stevenson, Claudina, Will, Christine, Wierda, and William G.: A first-in-human study of the potent and highly selective BTK degrader ABBV-101 in patients with relapsed/refractory B-cell malignancies. J Clin Oncol 16 Suppl (42): TPS7091,2024.
Academic Contact Information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
12th Floor, South Pavilion
Philadelphia,
PA
19104
Patient appointments: 800-789-7366